The clinical significance of the tumor cell D2-40 immunoreactivity in non-small cell lung cancer

Lung Cancer

Volumn 70, Issue 1, 2010, Pages 88-93

  Kadota, Kyuichi ^a   Huang, Cheng Long ^a   Liu, Dage ^a   Nakashima, Nariyasu ^a   Yokomise, Hiroyasu ^a   Ueno, Masaki ^a   Haba, Reiji ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

D2 40; Differentiation; Lung cancer; Prognosis; Proliferation

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY D2-40;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH VESSEL; MALE; MICROVASCULATURE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHANGIOGENESIS; MALE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL RATE;

EID: 77956183843     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.12.014     Document Type: Article

References (24)

1. Cersosimo R.J. Lung cancer: a review. Am J Health Syst Pharm 2002, 59:611-642.
2. Huang C., Liu D., Masuya D., Nakashima T., Kameyama K., Ishikawa S., et al. Clinical application of biological markers for treatments of resectable non-small-cell lung cancers. Br J Cancer 2005, 92:1231-1239.
3. Huang C., Yokomise H., Fukushima M., Kinoshita M. Tailor-made chemotherapy for non-small cell lung cancer patients. Future Oncol 2006, 2:289-299.
4. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990, 82:4-6.
5. Padera T.P., Kadambi A., di Tomaso E., Carreira C.M., Brown E.B., Boucher Y., et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296:1883-1886.
6. Matsuyama K., Chiba Y., Sasaki M., Tanaka H., Muraoka R., Tanigawa N. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Ann Thorac Surg 1998, 65:1405-1409.
7. Masuya D., Huang C., Liu D., Kameyama K., Hayashi E., Yamauchi A., et al. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer 2001, 92:2628-2638.
8. Marks A., Sutherland D.R., Bailey D., Iglesias J., Law J., Lei M., et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors. Br J Cancer 1999, 80:569-578.
9. Kahn H.J., Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002, 82:1255-1257.
10. Renyi-Vamos F., Tovari J., Fillinger J., Timar J., Paku S., Kenessey I., et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenetic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005, 11:7344-7353.
11. Kadota K., Huang C., Liu D., Ueno M., Kushida Y., Haba R., et al. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer 2008, 44:1057-1067.
12. Yonemura Y., Endou Y., Tabachi K., Kawamura T., Yun H.Y., Kameya T., et al. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol 2006, 37:1193-1199.
13. Arnaout-Alkarain A., Kahn H.J., Narod S.A., Sun P.A., Marks A.N. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 2007, 20:183-191.
14. Schacht V., Dadras S.S., Johnson L.A., Jackson D.G., Hong Y.K., Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005, 166:913-921.
15. Mimura T., Ito A., Sakuma T., Ohbayashi C., Yoshimura M., Tsubota N., et al. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma. Cancer 2007, 109:933-938.
16. Hinterberger M., Reineke T., Storz M., Weder W., Vogt P., Moch H. D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol 2007, 20:248-255.
17. Yang H.M., Cabral E., Dadras S.S., Cassarino D.S. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas. Am J Dermatopathol 2008, 30:549-554.
18. Ishida M., Kushima R., Okabe H. Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin. J Cutan Pathol 2008, 35:926-930.
19. Dumoff K.L., Chu C., Xu X., Pasha T., Zhang P.J., Acs G. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol 2005, 18:97-104.
20. Longatto-Filho A., Pinheiro C., Pereira S.M., Etlinger D., Moreira M.A., Jube L.F., et al. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol Oncol 2007, 107:45-51.
21. Iczkowski K.A., Butler S.L., Shanks J.H., Hossain D., Schall A., Meiers I., et al. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. Hum Pathol 2008, 39:275-281.
22. Wang S.L., Li S.H., Chen W.T., Chai C.Y. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma. APMIS 2007, 115:906-910.
23. Iwakiri S., Nagai S., Katakura H., Takenaka K., Date H., Wada H., et al. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung. Ann Surg Oncol 2009, 16:1678-1685.
24. Schacht V., Ramirez M.I., Hong Y.K., Hirakawa S., Feng D., Harvey N., et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003, 22:3546-3556.